David Lee, MD, professor of Clinical Urology at UCI Health, details the multidisciplinary team members and process that generated a same-day discharge clinical pathway for patients receiving robotic surgery for prostate cancer. Lee is a robotic surgery expert who has completed more than 6300 robotic surgical procedures
Cell-cycle risk score is predictive of ADT benefit in prostate cancer
May 17th 2024"Prolaris precisely describes the difference in metastasis outcomes for men receiving monotherapy (RT) vs multimodal therapy (RT+ADT), and further tells me precisely what the risk of death is for a man on surveillance," says Jonathan D. Tward, MD, PhD.